Synopsis
Synopsis
0
KDMF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Bisolvomycin
2. Geomycin
3. Hydroxytetracycline
4. Oxyterracin
5. Oxyterracine
6. Oxytetracid
7. Oxytetracycline
8. Oxytetracycline Anhydrous
9. Oxytetracycline Calcium
10. Oxytetracycline Dihydrate
11. Oxytetracycline Monohydrochloride
12. Oxytetracycline Sulfate (2:1)
13. Oxytetracycline, (4a Beta,5 Beta,5a Beta,12a Beta)-isomer
14. Oxytetracycline, (5 Beta)-isomer
15. Oxytetracycline, Anhydrous
16. Oxytetracycline, Calcium (1:1) Salt
17. Oxytetracycline, Disodium Salt, Dihydrate
18. Oxytetracycline, Sodium Salt
19. Terramycin
1. 2058-46-0
2. Oxytetracycline Hcl
3. Terramycin Hydrochloride
4. Oxytetracycline.hcl
5. Bisolvomycin
6. Terramycin
7. Dalimycin
8. Unimycin
9. Oxy-kesso-tetra
10. Alamycin
11. Imperacin
12. Mepatar
13. Oxacycline
14. Oxymykoin
15. Oxysteclin
16. Vendarcin
17. Oxytetracyclini Hydrochloridum
18. Dalinmycin
19. Engemycin
20. Oxamycen
21. Liquamycin Injectable
22. Aquacycline
23. Hydrocyclin
24. Oxybiocycline
25. Abbocin
26. Chrysocin
27. Elinton
28. Intaloxin
29. Liquachel
30. Macodyn
31. Otetryn
32. Oxlopar
33. Oxycycline
34. Oxyject
35. Oxytetral
36. Oxytetrin
37. Oxytracyl
38. Terraject
39. Toxinal
40. Biotet
41. Oxyvet
42. Oxy-dumocyclin
43. Tetra-tablinen
44. Oxy-terachel
45. Bi Steclin
46. Ia-loxin
47. Oxy-rivo
48. Uri-tet
49. Tetran Hydrochloride
50. 5-hydroxytetracycline Hydrochloride
51. Stecsolin
52. Oxydon
53. Tm 5
54. Oxy-tet 50
55. Tetracycline, 5-oxy-
56. Oxy-ws
57. Oxytetracycline (hydrochloride)
58. 4u7k4n52zm
59. Nsc 9169
60. Biosolvomycin
61. Chebi:31953
62. Oxy-de 250
63. 5-hydroxytetracycline Monohydrochloride
64. 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide Monohydrochloride
65. Ncgc00091268-01
66. Oxytet
67. Terramycin (tn)
68. Dsstox_cid_1097
69. Component Of Terramycin Topical Ointment
70. Dsstox_rid_75939
71. Dsstox_gsid_21097
72. (4s,4ar,5s,5ar,6s,12ar)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
73. Oxy Ws
74. Oxyject 100
75. Caswell No. 628
76. Oxytetracycline Hydrochloride 100 Microg/ml In Acetonitrile
77. Oxatet
78. Hydroxytetrazyklinhydrochlorid
79. Ccris 200
80. Cas-2058-46-0
81. Tm 5 (van)
82. Nsc-757262
83. (4s,4ar,5s,5ar,6s,12as)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide Hydrochloride
84. Einecs 218-161-2
85. Epa Pesticide Chemical Code 006308
86. Unii-4u7k4n52zm
87. Neo-oxy 100/100 Mr
88. Ai3-50164
89. Oxytetracycline Hydrochloride (internal Use)
90. (4s,4ar,5s,5ar,6s,12as)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
91. Oxytetracycline Hydrochloride [jan]
92. Oxytetracycline Hydrochloride [usp:jan]
93. 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, Monohydrochloride, (4s,4ar,5s,5ar,6s,12as)-
94. 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, Monohydrochloride, (4s-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha))-
95. Schembl124996
96. Spectrum1500457
97. Chembl1607480
98. Chembl4549546
99. Chembl4591469
100. Dtxsid5021097
101. Hy-b0275a
102. Hms1920f04
103. Pharmakon1600-01500457
104. Tox21_111109
105. Tox21_201850
106. Tox21_300601
107. Ccg-40206
108. Mfcd00135815
109. Nsc757262
110. S5199
111. Oxytetracycline For System Suitability
112. Akos015950811
113. Nc00526
114. Ncgc00164443-01
115. Ncgc00254367-01
116. Ncgc00259399-01
117. (4s,5s,6s,12as,4ar,5ar)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl -1,11-dioxo-4,5,6,12a,4a,5a-hexahydronaphthacene-2-carboxamide, Chloride
118. Ac-11614
119. Oxytetracycline Hydrochloride (jp17/usp)
120. Oxytetracycline Hydrochloride [mi]
121. Cs-0013151
122. O0475
123. Oxytetracycline Hydrochloride [mart.]
124. Oxytetracycline Hydrochloride [vandf]
125. Oxytetracycline Hydrochloride [usp-rs]
126. Oxytetracycline Hydrochloride [who-dd]
127. Oxytetracycline Hydrochloride [who-ip]
128. D01596
129. Oxytetracycline Hydrochloride [green Book]
130. Oxytetracycline Hydrochloride [orange Book]
131. Oxytetracycline Hydrochloride [ep Monograph]
132. Oxytetracycline Hydrochloride [usp Monograph]
133. Oxytetracyclini Hydrochloridum [who-ip Latin]
134. Q27114732
135. Oxytetracycline Hydrochloride, >=95% (hplc), Crystalline
136. Terra-cortril Component Oxytetracycline Hydrochloride
137. Oxytetracycline Hydrochloride Component Of Terra-cortril
138. Oxytetracycline Hydrochloride, Vetranal(tm), Analytical Standard
139. Oxytetracycline Hydrochloride, European Pharmacopoeia (ep) Reference Standard
140. Oxytetracycline Hydrochloride, United States Pharmacopeia (usp) Reference Standard
141. 15000-39-2
142. 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, Hydrochloride (1:1), (4s,4ar,5s,5ar,6s,12as)-
143. 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, Monohydrochloride, (4s-(4.alpha.,4a.alpha.,5.alpha.,5a.alpha.,6.beta.,12a.alpha.))-
144. Oxytetracycline Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
| Molecular Weight | 496.9 g/mol |
|---|---|
| Molecular Formula | C22H25ClN2O9 |
| Hydrogen Bond Donor Count | 8 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 2 |
| Exact Mass | 496.1248581 g/mol |
| Monoisotopic Mass | 496.1248581 g/mol |
| Topological Polar Surface Area | 202 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 1000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
API SUPPLIERS
Suanfarma, at the Core of a Better Life.
Click Us!
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13390
Submission : 1998-09-01
Status : Active
Type : II
Century has been an API manufacturer for over 40 years & is the partner of choice for multipurpose custom manufacturing projects.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34794
Submission : 2020-07-22
Status : Active
Type : II
Date of Issue : 2022-11-02
Valid Till : 2024-12-16
Written Confirmation Number : WC-0293
Address of the Firm :
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13640
Submission : 1998-09-01
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13574
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13368
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13452
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13471
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13489
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13490
Submission : 1998-09-01
Status : Inactive
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
Suanfarma, at the Core of a Better Life.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13390
Submission : 1998-09-01
Status : Active
Type : II
Century has been an API manufacturer for over 40 years & is the partner of choice for multipurpose custom manufacturing projects.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34794
Submission : 2020-07-22
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13464
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13452
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13490
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13368
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13489
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13471
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13349
Submission : 1998-09-01
Status : Inactive
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13506
Submission : 1998-09-01
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Solubilizers
Topical
Thickeners and Stabilizers
Parenteral
Fillers, Diluents & Binders
Direct Compression
Taste Masking
Emulsifying Agents
Controlled & Modified Release
Chewable & Orodispersible Aids
Coating Systems & Additives
Film Formers & Plasticizers
Surfactant & Foaming Agents
Lubricants & Glidants
Co-Processed Excipients
API Stability Enhancers
Granulation
Rheology Modifiers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
Analytical Methods
ABOUT THIS PAGE
14
PharmaCompass offers a list of Oxytetracycline Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Oxytetracycline Hydrochloride manufacturer or Oxytetracycline Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Oxytetracycline Hydrochloride manufacturer or Oxytetracycline Hydrochloride supplier.
PharmaCompass also assists you with knowing the Oxytetracycline Hydrochloride API Price utilized in the formulation of products. Oxytetracycline Hydrochloride API Price is not always fixed or binding as the Oxytetracycline Hydrochloride Price is obtained through a variety of data sources. The Oxytetracycline Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Oxyvet manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxyvet, including repackagers and relabelers. The FDA regulates Oxyvet manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxyvet API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Oxyvet manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Oxyvet supplier is an individual or a company that provides Oxyvet active pharmaceutical ingredient (API) or Oxyvet finished formulations upon request. The Oxyvet suppliers may include Oxyvet API manufacturers, exporters, distributors and traders.
click here to find a list of Oxyvet suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Oxyvet DMF (Drug Master File) is a document detailing the whole manufacturing process of Oxyvet active pharmaceutical ingredient (API) in detail. Different forms of Oxyvet DMFs exist exist since differing nations have different regulations, such as Oxyvet USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Oxyvet DMF submitted to regulatory agencies in the US is known as a USDMF. Oxyvet USDMF includes data on Oxyvet's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Oxyvet USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Oxyvet suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Oxyvet Drug Master File in Japan (Oxyvet JDMF) empowers Oxyvet API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Oxyvet JDMF during the approval evaluation for pharmaceutical products. At the time of Oxyvet JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Oxyvet suppliers with JDMF on PharmaCompass.
A Oxyvet CEP of the European Pharmacopoeia monograph is often referred to as a Oxyvet Certificate of Suitability (COS). The purpose of a Oxyvet CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Oxyvet EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Oxyvet to their clients by showing that a Oxyvet CEP has been issued for it. The manufacturer submits a Oxyvet CEP (COS) as part of the market authorization procedure, and it takes on the role of a Oxyvet CEP holder for the record. Additionally, the data presented in the Oxyvet CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Oxyvet DMF.
A Oxyvet CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Oxyvet CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Oxyvet suppliers with CEP (COS) on PharmaCompass.
A Oxyvet written confirmation (Oxyvet WC) is an official document issued by a regulatory agency to a Oxyvet manufacturer, verifying that the manufacturing facility of a Oxyvet active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Oxyvet APIs or Oxyvet finished pharmaceutical products to another nation, regulatory agencies frequently require a Oxyvet WC (written confirmation) as part of the regulatory process.
click here to find a list of Oxyvet suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Oxyvet as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Oxyvet API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Oxyvet as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Oxyvet and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Oxyvet NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Oxyvet suppliers with NDC on PharmaCompass.
Oxyvet Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Oxyvet GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Oxyvet GMP manufacturer or Oxyvet GMP API supplier for your needs.
A Oxyvet CoA (Certificate of Analysis) is a formal document that attests to Oxyvet's compliance with Oxyvet specifications and serves as a tool for batch-level quality control.
Oxyvet CoA mostly includes findings from lab analyses of a specific batch. For each Oxyvet CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Oxyvet may be tested according to a variety of international standards, such as European Pharmacopoeia (Oxyvet EP), Oxyvet JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oxyvet USP).
